Will Viemed Healthcare stock go up?

According to Danelfin AI, Viemed Healthcare has today an AI Score of 6/10 (Hold rating), because its probability of beating the market in 3 months (56.76%) is +5.94% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Viemed Healthcare stock?

The Viemed Healthcare target price is $12.04 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Viemed Healthcare stock right now?

Viemed Healthcare has today a Hold rating (AI Score 6/10), according to Danelfin AI. Its probability of beating the market in 3 months (56.76%) is +5.94% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Viemed Healthcare stock is a good buy .

Is Viemed Healthcare undervalued right now?

Based on analysts, the average price target downside for Viemed Healthcare is 0.00% (1Y). According to Danelfin AI, Viemed Healthcare has today an AI Score of 6/10 (Hold Rating).

What was the price range of Viemed Healthcare stock over the past 12 months?

The Viemed Healthcare stock price range over the past 12 months has been $5.93 - $12.04.

What is going on with Viemed Healthcare stock in the last 3 months?

The Viemed Healthcare stock performance in the last quarter has been +25.54%.

Does Viemed Healthcare offer dividend payments?

No, Viemed Healthcare does not currently pay dividends.

What is the current market capitalization of Viemed Healthcare?

Viemed Healthcare's market cap is $460.8M, as of 2026-07-03 08:00.

Viemed Healthcare Inc (VMD) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

VMD AI-Powered Stock Analysis

AI Score Explanation

AI Score

Hold

Fundamental
Technical
Sentiment
Low Risk

According to Danelfin’s proprietary AI model, Viemed Healthcare Inc today receives an AI Score of 6/10, which translates to a Hold rating. The stock has a 57% probability of outperforming the market in the next 3 months, which is 6% higher than the average probability of any stock (51%). This elevated probability is supported by several positive contributors: the long tail of fundamentals signals adds +3.53%, the 180-day chart pattern adds +1.62%, and operating cash flow (in the top 50%) adds +0.55%. On the other hand, detractors include the 60-day chart pattern (-0.86%), the 90-day chart pattern (-0.49%), and the Fear & Greed Index at 31 (-0.48%), indicating fearful sentiment. Notable data points include a strong Alpha 1Y of 0.51, ranking in the top 20%, which reflects excellent risk-adjusted returns over the past year. However, Cash per Share is only $0.25, ranking in the bottom 20%, indicating low liquidity. The Earnings Countdown of -52 days (past earnings) is also in the bottom 20%, but positively influences the probability. Overall, the stock benefits from solid fundamentals and technical patterns, but faces headwinds from short-term chart patterns and low cash reserves, resulting in a balanced HOLD rating.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Valuation+3.20%
How the stock is priced relative to its fundamentals
Momentum+1.72%
Direction and strength of recent price movements
Earnings Quality+0.73%
Stability and reliability of reported earnings
Growth+0.25%
Expected pace of revenue and earnings expansion
Size & Liquidity+0.20%
Company size and trading liquidity
Volatility+0.16%
How much the stock price tends to fluctuate

Sentiment-0.33%
How analysts and the market view the stock

VMD probability advantage of beating the market (3M):

+5.94%

Technical

Viemed Healthcare (VMD) has a Technical Score of 9/10 because, according to only technical analysis, it has a probability advantage of +7.71% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.73%) and the probability of VMD (58.44%) of overperforming the market in the next 3 months, as determined by Danelfin AI’s technical analysis.

Average probability of any US-listed stock of beating the market (3M)50.73%
VMD probability advantage of beating the market (only technical, 3M)+7.71%
VMD probability of beating the market (3M)58.44%

VMD probability advantage of beating the market (only technical, 3M): +7.71%

The AI-powered technical analysis of Viemed Healthcare (VMD) is only based on the 30 technical features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of VMD:

Type	Alpha Signal	Probability Advantage Impact (3M)
Technical	Upgrade to Pro to unlock	+3.22%
Technical	Upgrade to Pro to unlock	+1.74%
Technical	Upgrade to Pro to unlock	-1.34%
Technical	Upgrade to Pro to unlock	+1.18%
Technical	Upgrade to Pro to unlock	-0.87%
Technical	Upgrade to Pro to unlock	-0.63%
Technical	Upgrade to Pro to unlock	+0.62%
Technical	Upgrade to Pro to unlock	+0.57%
Technical	Upgrade to Pro to unlock	+0.38%
Technical	Upgrade to Pro to unlock	+0.34%
Technical	Upgrade to Pro to unlock	-0.33%
Technical	Upgrade to Pro to unlock	+0.32%
Technical	Upgrade to Pro to unlock	+0.32%
Technical	Upgrade to Pro to unlock	+0.29%
Technical	Upgrade to Pro to unlock	+0.29%

Rest of Alpha Signals: +1.61%

VMD probability advantage of beating the market (only technical, 3M)Total:+7.71%
VMD Technical Score

Significant changes Vs previous day

VMD Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$12.04
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro) or AI Score < 4/10
Take Profit:$XXXXXPro (XXXXX
Pro
) or AI Score < 4/10

VMD Proven Hold Signal & Price Forecast

This is the price chart for VMD from January 2, 2026 until today. The chart indicates, in yellow, the 51 days when the stock received a Hold rating (hold signals, AI Score 4 to 6).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Hold signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Hold signals

Forecast:

1 Month
3 Months
6 Months
1 Year

VMD Average Past Performance & Win Rate

Three months after its 1137 Hold signals since July 2026, VMD had an average performance of xxxxxx and a xxxxxx Win rate (positive performance).

1137 Past VMD Hold Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				+0.07%
Average Alpha				-14.64%
Win Rate (% Positive Perf.)				45.13%
% Positive Alpha				28.81%

VMD Frequently Asked Questions

Will Viemed Healthcare stock go up?
According to Danelfin AI, Viemed Healthcare has today an AI Score of 6/10 (Hold rating), because its probability of beating the market in 3 months (56.76%) is +5.94% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Viemed Healthcare stock?
Is it a good time to buy, sell, or hold Viemed Healthcare stock right now?
Is Viemed Healthcare undervalued right now?
What was the price range of Viemed Healthcare stock over the past 12 months?
What is going on with Viemed Healthcare stock in the last 3 months?
Does Viemed Healthcare offer dividend payments?
What is the current market capitalization of Viemed Healthcare?

Viemed Healthcare Inc Company Profile

Viemed Healthcare, Inc. along with its affiliate corporations, is a principal provider of domiciliary medical equipment and post-acute respiratory healthcare services across the states. The company primarily offers a diverse range of respiratory disease management solutions, notably focusing on the treatment of chronic obstructive pulmonary disease (COPD). Among its primary therapeutic offerings are non-invasive ventilation techniques, percussion vests, and an array of other therapies targeting COPD.

To cater to patients suffering from COPD, Viemed Healthcare actively leases medical devices including both non-invasive and invasive ventilators, positive airway pressure appliances (PAP), robust medical equipment, percussion vests, oxygen concentrators along with other critical medical apparatuses. The company's product portfolio even extends to sales and rentals of durable home medical equipment devices.

Beyond these offerings, Viemed takes pride in providing comprehensive neuromuscular care services alongside oxygen therapy facilities. It also addresses sleep apnea through effective sleep management strategies offering related solutions or equipment like PAP machines, automatic continuous positive airway pressure tools and bi-level positive airway pressure devices.

Moreover, Viemed Healthcare also extends its services into the realm of home-based sleep apnea screening in addition to offering healthcare staffing and recruitment amenities.

Originating back in 2006, the Viemed Healthcare enterprise has ever since been stationed at its head office located in Lafayette Louisiana.

Sector:
Country:United States
Industry:
Address:625 E. Kaliste Saloom Rd., Lafayette
Employees:1,387
Website:viemed.com

Pros

Demographic tailwinds from aging population and chronic respiratory conditions

Cost-efficiency of home-based care compared to institutional settings

Patient and provider inertia with established respiratory therapy equipment

Regulatory and accreditation hurdles for new home medical equipment entrants

Recurring revenue stream from equipment rentals and consumable supplies

Cons

Ongoing pressure on reimbursement rates from government and private payers

Extensive regulatory compliance requirements for home healthcare services

Reliance on physician referral networks for patient acquisition

Capital expenditure requirements for medical equipment inventory

Vulnerability to changes in healthcare policy and reimbursement frameworks

VMD Stock AI Analysis